Pulmonary Rehabilitation for COPD Patients: Can Performance Predict Exacerbation?
NCT ID: NCT05492149
Last Updated: 2026-01-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
150 participants
OBSERVATIONAL
2022-09-01
2024-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Pulmonary Rehabilitation Following Acute COPD Exacerbation
NCT00557115
COPD-EXA-REHAB. Early Pulmonary Rehabilitation of Patients With Acute Exacerbation of COPD
NCT02987439
Effectiveness and Tolerance of Respiratory Rehabilitation in Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease
NCT07202793
Characteristics of People With Advanced Chronic Obstructive Pulmonary Disease (COPD) - A Multicenter Study
NCT04249388
Long Term Effects and of a Pulmonary Rehabilitation Maintenance Program
NCT03704935
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pulmonary rehabilitation group
Patients referred for a pulmonary rehabilitation program will be follow up.
Performance follow-up
Diary performance during rehabilitation will be collected and a CAT questionnaire will be completed by the patient.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Performance follow-up
Diary performance during rehabilitation will be collected and a CAT questionnaire will be completed by the patient.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* COPD patients
Exclusion Criteria
* Occurence of an adverse event that prevents further rehabilitation
* Exacerbation in the previous month
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Groupe Hospitalier du Havre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Groupe Hospitalier du Havre
Montivilliers, Groupe Hospitalier Du Havre, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-A00210-43
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.